| Dr Michael Deane Stamatakos, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-4001 | |
| (703) 776-7113 |
| Full Name | Dr Michael Deane Stamatakos |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 37 Years |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437202157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 0101252133 (Virginia) | Primary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D0037864 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services - Pathology | 8426241647 | 34 |
| Inova Health Care Services - Pathology | 8426241647 | 34 |
News Archive
Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.
TeleHealth Services, the nation's leading provider of interactive patient education systems and healthcare grade televisions for hospitals, today announced the launch of the High Blood Pressure and Stroke Awareness Campaign in support of National Stroke Awareness month, which takes place in May every year.
Ardea Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering.
Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.
› Verified 9 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.
TeleHealth Services, the nation's leading provider of interactive patient education systems and healthcare grade televisions for hospitals, today announced the launch of the High Blood Pressure and Stroke Awareness Campaign in support of National Stroke Awareness month, which takes place in May every year.
Ardea Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering.
Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.
› Verified 9 days ago
| Entity Name | Inova Health Care Services - Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427369578 PECOS PAC ID: 8426241647 Enrollment ID: O20101020001195 |
News Archive
Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.
TeleHealth Services, the nation's leading provider of interactive patient education systems and healthcare grade televisions for hospitals, today announced the launch of the High Blood Pressure and Stroke Awareness Campaign in support of National Stroke Awareness month, which takes place in May every year.
Ardea Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering.
Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Deane Stamatakos, MD 11701 Milbern Dr, Potomac, MD 20854-3525 Ph: (301) 299-9424 | Dr Michael Deane Stamatakos, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-4001 |
News Archive
Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.
TeleHealth Services, the nation's leading provider of interactive patient education systems and healthcare grade televisions for hospitals, today announced the launch of the High Blood Pressure and Stroke Awareness Campaign in support of National Stroke Awareness month, which takes place in May every year.
Ardea Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering.
Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.
› Verified 9 days ago
Tuyethoa N. Vinh, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-3623 | |
Philip Andrew Branton, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3428 | |
Dr. Abdus Salam, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Road, Falls Church, VA 22042 Phone: 703-776-1110 | |
Roy R Zhang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Kamyar Khazaeian, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Michelle D Xia, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Lucia Pastore, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-2746 |